Skip to main content
Clinical Trials/NCT05191732
NCT05191732
Completed
Not Applicable

The Therapeutic Effect of Autologous Platelet-Rich Plasma Versus Bone Marrow Concentrate in Anterior Cruciate Ligament Reconstruction - A Prospective, Double-Blind Randomized Controlled Study

Kaohsiung Medical University Chung-Ho Memorial Hospital1 site in 1 country30 target enrollmentAugust 3, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anterior Cruciate Ligament Reconstruction
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Enrollment
30
Locations
1
Primary Endpoint
MRI
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Anterior cruciate ligament (ACL) is an important stabilizer of knee during daily activity and exercise. The ruptured ACL need to be reconstructed by a new tendon graft which passed the bone tunnel and joint during operation. How to enhance the tendon graft to bone tunnel healing is critical important to prevent recurrent ligament laxity, avoid secondary osteoarthritis, and achieve early return to sports and work.

Platelet Rich Plasma (PRP),harvest from peripheral blood, is rich in multiple growth factors(i.e. VEGF, PDGD, TGFB, IGF, EGF) which help the injured tissue regeneration. Bone marrow stem cell has been demonstrated to enhance the injured tissue repair both in vitro and in vivo study.

However, there is no prospective study in comparing the PRP and BMC to enhance interfacial healing between graft and bone tunnel in ACL reconstruction. Investigators hypothesize that the combination of PRP and BMC has synergetic effect in interfacial healing in ACL reconstruction.

Aim of this study: To investigate the result of clinical functional scoring, MRI, and biomechanical study between PRP augmentation, PRP+BMC augmentation and traditional ACL reconstruction.

Detailed Description

Anterior cruciate ligament (ACL) is an important stabilizer of knee during daily activity and exercise. According to literature, there are 100,000- 200,000 ACL tear case annually in US. The patients with ACL tear will sustain with joint pain, muscle weakness, giving way sensation, other knee ligaments or meniscus injury, and consequent osteoarthritis change. However, the ruptured ACL cannot heal by itself due to limited vascularity supply, intraarticular inflammatory factors which inhibit the ACL cells migration and proliferation. The ruptured ACL need to be reconstructed by a new tendon graft which passed the bone tunnel and joint during operation. How to enhance the tendon graft to bone tunnel healing is critical important to prevent recurrent ligament laxity, avoid secondary osteoarthritis, and achieve early return to sports and work. Platelet Rich Plasma (PRP),harvest from peripheral blood, is rich in multiple growth factors(i.e. VEGF, PDGD, TGFB, IGF, EGF) which help the injured tissue regeneration. The PRP has been applied in treating tendinitis, osteoarthritis, cartilage injury, and bone nonunion. Bone marrow contains lots of stem cell and progenitor cells with capability of self-renewal and multi-differentiation. Bone marrow stem cell has been demonstrated to enhance the injured tissue repair both in vitro and in vivo study. The bone marrow concentrate (BMC) can be isolated from the bone marrow through the centrifuge procedure at one time which contains multiple stem cells. The bone marrow can regenerate itself around 1 week. In recent years, many authors uses the combination of RPP and BMC to treat injured tissue. However, there is no prospective study in comparing the PRP and BMC to enhance interfacial healing between graft and bone tunnel in ACL reconstruction. Investigators hypothesize that the combination of PRP and BMC has synergetic effect in interfacial healing in ACL reconstruction. The purpose of this study is to investigate the clinical outcome of autologous PRP, and combined BMC+PRP in tendon graft augmentation in the ACL reconstruction surgery with functional score and MRI evaluation. Investigators will analyze the therapeutic effect using one-way ANOVA. To investigate the result of clinical functional scoring, MRI, and biomechanical study between PRP augmentation, PRP+BMC augmentation and traditional ACL reconstruction.

Registry
clinicaltrials.gov
Start Date
August 3, 2018
End Date
July 4, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age ≧ 20 year-old
  • the patient has been confirmed ACL rupture and the reconstruction is indicated
  • sign IRB and operation consent

Exclusion Criteria

  • combined other ligament or extremities injury
  • prior the same knee surgery
  • open wound or operation history at knee joint
  • Severe knee osteoarthritis
  • history of multiple joint arthritis or rheumatoid arthritis
  • Systemic diseases (infections, malignancies, immunodepression)
  • patients with bleeding tendency, anticoagulant or antiaggregant therapies
  • patients with Hb values \< 11 g/dl and/or platelet values \< 150,000/mm
  • refuse to sign Informed Consent Form and operation consent

Outcomes

Primary Outcomes

MRI

Time Frame: preoperative

MRI to evaluate the joint space, graft to bone healing status and graft incorporation.

MRI of operated knee

Time Frame: 12 months after ACL reconstruction.

MRI to evaluate the joint space, graft to bone healing status and graft incorporation.

Muscle power (N.m/kg)

Time Frame: 12 months after ACL reconstruction.

muscle power test by Biodex System 3 Pro

Proprioception (degree)

Time Frame: 12 months after ACL reconstruction.

Proprioception test by Biodex System 3 Pro

X-ray

Time Frame: 12 months after ACL reconstruction.

X-ray to evaluate the joint space, graft to bone healing status and graft incorporation.

Lysholm score

Time Frame: 12 months after ACL reconstruction.

Lysholm score to evaluate the knee function recovery

IKDC 2000

Time Frame: 12 months after ACL reconstruction.

IKDC 2000 to evaluate the knee function recovery

Study Sites (1)

Loading locations...

Similar Trials